Postnatally acquired cytomegalovirus (CMV) is commonly acquired via breast milk, with premature infants more frequently developing symptoms of CMV infection in comparison to term infants. Meningitis is a rare clinical manifestation of CMV infection. The diagnosis of meningitis is difficult to make in infants, particularly those who are preterm. Consequentially, broad-spectrum empiric antimicrobial coverage is often administered for several days while waiting for current gold standard CSF testing to result. The BioFire FilmArray (BFA) simultaneously tests for 14 different pathogens, including CMV, allowing for quicker diagnosis and shorter time to definitive treatment. Here, we report a very low birth weight infant with postnatally acquired CMV meningitis, the first to our knowledge to be diagnosed using the BioFire FilmArray.
LanzieriTM, DollardSC, JosephsonCD, SchmidDS, BialekSR. Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics. 2013;131(6):e1937–1945.
2.
OkuluE, AkinIM, AtasayB, CiftciE, ArsanS, TurmenT. Severe postnatal cytomegalovirus infection with multisystem involvement in an extremely low birth weight infant. J Perinatol. 2012;32(1):72–4.
3.
NijmanJ, de VriesLS, Koopman-EsseboomC, UiterwaalCS, van LoonAM, Verboon-MaciolekMA. Postnatally acquired cytomegalovirus infection in preterm infants: A prospective study on risk factors and cranial ultrasound findings. Arch Dis Child Fetal Neonatal Ed. 2012;97(4):F259–263.
4.
FischerC, MeylanP, Bickle GrazM, GudinchetF, VaudauxB, BergerC, et al. Severe postnatally acquired cytomegalovirus infection presenting with colitis, pneumonitis and sepsis-like syndrome in an extremely low birthweight infant. Neonatology. 2010;97(4):339–45.
5.
Vicetti MiguelCP, MejiasA, RamiloO, ArduraMI, SanchezPJ. Cytomegalovirus meningitis in an infant with severe combined immunodeficiency. J Pediatr. 2016;173:235–7.
6.
AleemS, GreenbergRG. When to include a lumbar puncture in the evaluation for neonatal sepsis. NeoReviews. 2019;20(3):e124.
7.
LeberAL, EverhartK, Balada-LlasatJM, CullisonJ, DalyJ, HoltS, et al. Multicenter evaluation of BioFire FilmArray meningitis/encephalitis panel for detection of bacteria, viruses, and yeast in cerebrospinal fluid specimens. J Clin Microbiol. 2016;54(9):2251–61.
8.
BlaschkeAJ, HolmbergKM, DalyJA, LeberAL, Dien BardJ, KorgenskiEK, et al. Retrospective evaluation of infants aged 1 to 60 days with residual cerebrospinal fluid (csf) tested using the filmarray meningitis/encephalitis (me) panel. J Clin Microbiol. 2018;56(7):e00277–18.
9.
ChangD, OkuliczJF, NielsenLE, WhiteBK. A Tertiary Care Center’s Experience with novel molecular meningitis/encephalitis diagnostics and implementation with antimicrobial stewardship. Mil Med. 2018;183(1-2):e24–e27.
10.
EichingerA, HagenA, Meyer-BuhnM, HuebnerJ. Clinical benefits of introducing real-time multiplex PCR for cerebrospinal fluid as routine diagnostic at a tertiary care pediatric center. Infection. 2019;47(1):51–8.
11.
ExlerS, DaimingerA, GrotheM, SchalastaG, EndersG, EndersM. Primary cytomegalovirus (CMV) infection in pregnancy: Diagnostic value of CMV PCR in saliva compared to urine at birth. J Clin Virol. 2019;117:33–6.
12.
BoppanaSB, RossSA, ShimamuraM, PalmerAL, AhmedA, MichaelsMG, et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364(22):2111–8.
13.
GoelzR, HamprechtK, KlingelK, PoetsCF. Intestinal manifestations of postnatal and congenital cytomegalovirus infection in term and preterm infants. J Clin Virol. . 2016;83:29–36.
14.
Dien BardJ, AlbyK. Point-counterpoint: Meningitis/encephalitis syndromic testing in the clinical laboratory. J Clin Microbiol. 2018;56(4):e00018–18.
15.
HansonKE, SlechtaES, KillpackJA, HeyrendC, LuntT, DalyJA, et al. Preclinical assessment of a fully automated multiplex pcr panel for detection of central nervous system pathogens. J Clin Microbiol. 2016;54(3):785–7.
16.
TansarliGS, ChapinKC. Diagnostic test accuracy of the BioFire(R) FilmArray(R) meningitis/encephalitis panel: A systematic review and meta-analysis. Clin Microbiol Infect. 2020;26(3):281–90.
17.
MukhopadhyayS, MeyerSA, PermarSR, PuopoloKM. Symptomatic postnatal cytomegalovirus testing among very low-birth-weight infants: Indications and outcomes. Am J of Perinatol. 2016;33(9):894–902.
18.
MehlerK, OberthuerA, Lang-RothR, KribsA. High rate of symptomatic cytomegalovirus infection in extremely low gestational age preterm infants of 22-24 weeks’ gestation after transmission via breast milk. Neonatology. 2014;105(1):27–32.
19.
KellyMS, BenjaminDK, PuopoloKM, LaughonMM, ClarkRH, MukhopadhyayS, et al. Postnatal cytomegalo-virus infection and the risk for bronchopulmonary dysplasia. JAMA Pediatr. 2015;169(12):e153785.
20.
WeimerKED, KellyMS, PermarSR, ClarkRH, GreenbergRG. Association of adverse hearing, growth, and discharge age outcomes with postnatal cytomegalovirus infection in infants with very low birth weight. JAMA Pediatr. 2020;174(2):133–40.
21.
GoelzR, MeisnerC, BevotA, HamprechtK, Kraegeloh-MannI, PoetsCF. Long-term cognitive and neurological outcome of preterm infants with postnatally acquired CMV infection through breast milk. Arch Dis Child Fetal Neonatal Ed. 2013;98(5):F430–433.
22.
VollmerB, Seibold-WeigerK, Schmitz-SalueC, HamprechtK, GoelzR, Krageloh-MannI, et al. Postnatally acquired cytomegalovirus infection via breast milk: Effects on hearing and development in preterm infants. Pediatr. Infect Dis J. 2004;23(4):322–7.
23.
BrechtKF, GoelzR, BevotA, Krageloh-MannI, WilkeM, LidzbaK. Postnatal human cytomegalovirus infection in preterm infants has long-term neuropsychological sequelae. J Pediatr. 2015;166(4):834–9.
24.
BialasKM, SwamyGK, PermarSR. Perinatal cytomega-lovirus and varicella zoster virus infections: epidemiology prevention and treatment. Clin Perinatol. 2015;42(1):61–75, viii.
